The Patent Finder

Solvay Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Solvay Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Solvay Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,702,155Metered dose dispenser
Formerly held
Term ended
Term ended Sep 18, 2021 · From the USPTO record
Term endedTerm ended Sep 18, 2021From the USPTO record
US 7,547,708N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof
Lapsed on the fee record
Ended Jun 16, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 16, 2021From the USPTO record
US 7,297,699Piperazine and piperidine compounds
Term ended
Ended no later than May 10, 2021 · From the USPTO record
Term endedEnded no later than May 10, 2021From the USPTO record
US 7,435,738Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
Lapsed on the fee record
Ended Oct 14, 2020 · From the USPTO record
Lapsed on the fee recordEnded Oct 14, 2020From the USPTO record
US 7,456,182Phenylpiperazines
Term ended
Ended no later than Aug 22, 2020 · From the USPTO record
Term endedEnded no later than Aug 22, 2020From the USPTO record
US 7,375,127Novel Tetrahydrocarbazole Derivatives Having Improved Biological Action and Improved Solubility as Ligands of G-Protein Coupled Receptors (GPCRS)
Formerly held
Lapsed on the fee record
Ended May 20, 2020 · High confidence
Lapsed on the fee recordEnded May 20, 2020High confidence
US 7,342,032Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity
Lapsed on the fee record
Ended Mar 11, 2020 · From the USPTO record
Lapsed on the fee recordEnded Mar 11, 2020From the USPTO record
US 7,271,1891H-imidazole derivatives as cannabinoid receptor modulators
Lapsed on the fee record
Ended Sep 18, 2019 · From the USPTO record
Lapsed on the fee recordEnded Sep 18, 2019From the USPTO record
US 7,605,162Phenylpiperazine
Lapsed on the fee record
Ended Oct 20, 2017 · From the USPTO record
Lapsed on the fee recordEnded Oct 20, 2017From the USPTO record
US 6,906,059Pharmaceutical composition with protective action against oxidative/toxic substances, especially cardiotoxic substances
Lapsed on the fee record
Ended Jun 14, 2017 · From the USPTO record
Lapsed on the fee recordEnded Jun 14, 2017From the USPTO record
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited